North Star Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$30K | – | 1346 |
|
|
2022
Q3 | $30K | Hold |
3,000
| – | – | ﹤0.01% | 626 |
|
|
2022
Q2 | $33K | Hold |
3,000
| – | – | ﹤0.01% | 631 |
|
|
2022
Q1 | $34K | Hold |
3,000
| – | – | ﹤0.01% | 660 |
|
|
2021
Q4 | $47K | Hold |
3,000
| – | – | ﹤0.01% | 627 |
|
|
2021
Q3 | $51K | Hold |
3,000
| – | – | ﹤0.01% | 585 |
|
|
2021
Q2 | $65K | Sell |
3,000
-2,000
| -40% | -$35.8K | 0.01% | 540 |
|
|
2021
Q1 | $75K | Hold |
5,000
| – | – | 0.01% | 490 |
|
|
2020
Q4 | $66K | Hold |
5,000
| – | – | 0.01% | 496 |
|
|
2020
Q3 | $48K | Hold |
5,000
| – | – | 0.01% | 523 |
|
|
2020
Q2 | $57K | Hold |
5,000
| – | – | 0.01% | 472 |
|
|
2020
Q1 | $52K | Hold |
5,000
| – | – | 0.01% | 483 |
|
|
2019
Q4 | $82K | Hold |
5,000
| – | – | 0.01% | 465 |
|
|
2019
Q3 | $66K | Buy |
+5,000
| New | +$69.7K | 0.01% | 498 |
|
|
2019
Q2 | – | Sell |
-5,000
| Closed | -$92K | – | 912 |
|
|
2019
Q1 | $92K | Hold |
5,000
| – | – | 0.01% | 454 |
|
|
2018
Q4 | $131K | Hold |
5,000
| – | – | 0.02% | 381 |
|
|
2018
Q3 | $115K | Hold |
5,000
| – | – | 0.01% | 423 |
|
|
2018
Q2 | $95K | Hold |
5,000
| – | – | 0.01% | 459 |
|
|
2018
Q1 | $84K | Hold |
5,000
| – | – | 0.01% | 474 |
|
|
2017
Q4 | $76K | Hold |
5,000
| – | – | 0.01% | 479 |
|
|
2017
Q3 | $90K | Hold |
5,000
| – | – | 0.01% | 451 |
|
|
2017
Q2 | $82K | Hold |
5,000
| – | – | 0.01% | 455 |
|
|
2017
Q1 | $70K | Hold |
5,000
| – | – | 0.01% | 468 |
|
|
2016
Q4 | $80K | Hold |
5,000
| – | – | 0.01% | 424 |
|
|
2016
Q3 | $83K | Hold |
5,000
| – | – | 0.01% | 360 |
|
|
2016
Q2 | $56K | Hold |
5,000
| – | – | 0.01% | 392 |
|
|
2016
Q1 | $42K | Hold |
5,000
| – | – | 0.01% | 417 |
|
|
2015
Q4 | $47K | Hold |
5,000
| – | – | 0.01% | 403 |
|
|
2015
Q3 | $56K | Hold |
5,000
| – | – | 0.01% | 390 |
|
|
2015
Q2 | $63K | Hold |
5,000
| – | – | 0.01% | 376 |
|
|
2015
Q1 | $46K | Hold |
5,000
| – | – | 0.01% | 392 |
|
|
2014
Q4 | $72K | Hold |
5,000
| – | – | 0.01% | 351 |
|
|
2014
Q3 | $52K | Hold |
5,000
| – | – | 0.01% | 367 |
|
|
2014
Q2 | $81K | Hold |
5,000
| – | – | 0.02% | 337 |
|
|
2014
Q1 | $81K | Buy |
+5,000
| New | +$71.1K | 0.02% | 337 |
|
Other funds holding VNDA
EIP
North Star Investment Management's VNDA Position: Q4 2022 in Review
North Star Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2022, closing a stake of 3,000 shares — an estimated $30K sold.
North Star Investment Management first reported a position in VNDA in Q1 2014 and held it in 34 quarters. The position peaked at $131K in Q4 2018. 190 funds tracked by Wall St. Rank hold VNDA as of Q4 2022.
- North Star Investment Management reported no remaining Vanda Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- North Star Investment Management sold 3,000 Vanda Pharmaceuticals shares in Q4 2022, an estimated $30K.
- North Star Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 34 quarters.
- North Star Investment Management's Vanda Pharmaceuticals position peaked at $131K in Q4 2018.
- 190 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2022.
Based on North Star Investment Management's 13F filing for Q4 2022, filed 11 Jan 2023.